zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibatterici per uso sistemico, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
cefaclor ratio. sosp fl 100ml
ratiopharm italia srl - cefacloro monoidrato - sospensione os - "250 mg/5 ml granulato per sospensione orale" flacone da 100 ml
eritrocina
amdipharm ltd - eritromicina - eritromicina
vancocina a.p.
vancocin italia srl - vancomicina - vancomicina
cromezin
so.se.pharm s.r.l. societa' di servizio per l'industria farmaceutica ed affini - cefazolina - cefazolina
cefam
magis farmaceutici srl - cefamandolo - cefamandolo
supero
lifepharma s.p.a. - cefuroxime - cefuroxime
lukadin
lanova farmaceutici s.r.l. - amikacina - amikacina
eposerin
pfizer italia s.r.l. - ceftizoxima - ceftizoxima
cefodie
mediolanum farmaceutici s.p.a. - cefonicid - cefonicid